Exhibit 10.9S

2008 COMPENSATION INFORMATION FOR EXECUTIVE OFFICERS

The table below provides certain information
regarding (i) the annual base salaries as of January 1, 2008 of the current executive officers of Tercica, Inc. (the Company) listed below; (ii) the number of shares of the Companys common stock subject to
stock options granted in March 2008 to the executive officer of the Company listed below (and, with respect to Dr. Scarlett, in April 2008); and (iii) the number of restricted stock units (RSUs) granted in March 2008 to
the executive officers of the Company listed below (and, with respect to Dr. Scarlett, in April 2008):



|                                                                                                                   |  |                          |  |                                             |  |                    
|------------------------------------------------------------------------------------------------------------------ |  | ------------------------ |  | ------------------------------------------- |  | -------------------
|Executive Officer                                                                                                  |  | 2008AnnualBase Salary($) |  | Number ofSharesSubject toStockOptions(#)(1) |  | Numberof RSUs(#)(2)
|John A. Scarlett, M.D. Chief Executive Officer                                                                     |  | 520,000                  |  | 133,000                                     |  | 33,500             
|Ross G. Clark, Ph.D. Chief Technology Officer                                                                      |  | 340,000                  |  | 40,000                                      |  | 10,000             
|Richard A. King(3) President and Chief Operating
Officer                                                           |  | 435,000                  |  | 73,000                                      |  | 21,000             
|Ajay Bansal Executive Vice President and Chief Financial Officer                                                   |  | 350,000                  |  | 57,000                                      |  | 14,000             
|Stephen N. Rosenfield Executive Vice President of Legal Affairs, General Counsel and Secretary                     |  | 345,000                  |  | 55,500                                      |  | 13,500             
|Thorsten von Stein, M.D., Ph.D. Chief Medical Officer and Senior Vice President of Clinical and Regulatory Affairs |  | 340,000                  |  | 55,500                                      |  | 13,500             
|Andrew J. Grethlein, Ph.D. Senior Vice President, Pharmaceutical Operations                                        |  | 310,000                  |  | 55,500                                      |  | 13,500             
|Susan Wong Vice President, Finance and Chief Accounting Officer                                                    |  | 265,000                  |  | 26,500                                      |  | 6,750              



|(1) | Options vest over a period of four years subject to continuous service and were granted with an exercise price equal to the fair market value on the date of grant (as determined in
accordance with the Companys 2004 Stock Plan, as amended).
|--- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|(2) | The RSUs vest as follows: (i) 25% of RSUs will vest, if at all, if the executive officer is an employee of the Company on the 13th month anniversary of the date of grant,
(ii) another 25% of the RSUs will vest, if at all, if the executive officer is an employee of the Company on the 24th month anniversary of the date of grant, (iii) another 25% of the RSUs will vest, if at all, if the executive officer is
an employee of the Company on the 36th month anniversary of the date of grant and (iv) the remaining 25% of the RSUs will vest, if at all, if the executive officer is an employee of the Company on the 48th month anniversary day of grant. In the
event that one or more RSUs vest, the Company will deliver to the executive officer one share of the Companys common stock for each RSU that has vested.
|--- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|(3) | Mr. King was appointed as the Companys President on February 27, 2008.
|--- | -----------------------------------------------------------------------